"Viral Load" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.
| Descriptor ID |
D019562
|
| MeSH Number(s) |
E01.370.225.875.950 E05.200.875.950 G06.920.850
|
| Concept/Terms |
Viral Load- Viral Load
- Load, Viral
- Viral Burden
- Burden, Viral
|
Below are MeSH descriptors whose meaning is more general than "Viral Load".
Below are MeSH descriptors whose meaning is more specific than "Viral Load".
This graph shows the total number of publications written about "Viral Load" by people in this website by year, and whether "Viral Load" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 1 | 7 | 8 |
| 2005 | 1 | 5 | 6 |
| 2006 | 2 | 5 | 7 |
| 2007 | 4 | 5 | 9 |
| 2008 | 1 | 7 | 8 |
| 2009 | 5 | 6 | 11 |
| 2010 | 6 | 23 | 29 |
| 2011 | 7 | 18 | 25 |
| 2012 | 5 | 16 | 21 |
| 2013 | 7 | 17 | 24 |
| 2014 | 7 | 25 | 32 |
| 2015 | 8 | 21 | 29 |
| 2016 | 4 | 24 | 28 |
| 2017 | 4 | 29 | 33 |
| 2018 | 4 | 21 | 25 |
| 2019 | 14 | 27 | 41 |
| 2020 | 14 | 24 | 38 |
| 2021 | 7 | 27 | 34 |
| 2022 | 1 | 17 | 18 |
| 2023 | 0 | 11 | 11 |
| 2024 | 4 | 6 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Viral Load" by people in Profiles.
-
The HIV Care Cascade for Older Adults in Rural South Africa: A Longitudinal Cohort Study (2014-2019). J Acquir Immune Defic Syndr. 2024 08 01; 96(4):334-340.
-
Longitudinal Trajectories of Antiretroviral Treatment Adherence and Associations With Durable Viral Suppression Among Adolescents Living With HIV in South Africa. J Acquir Immune Defic Syndr. 2024 06 01; 96(2):171-179.
-
Attrition Rates in HIV Viral Load Monitoring and Factors Associated With Overdue Testing Among Children Within South Africa's Antiretroviral Treatment Program: Retrospective Descriptive Analysis. JMIR Public Health Surveill. 2024 May 14; 10:e40796.
-
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15?years. Contemp Clin Trials. 2024 Jul; 142:107540.
-
Socio-Behavioural Barriers to Viral Suppression in the Older Adult Population in Rural South Africa. AIDS Behav. 2024 Jul; 28(7):2307-2313.
-
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study. Lancet HIV. 2024 May; 11(5):e300-e308.
-
Assessment of the performance of the plasma separation card for HIV-1 viral load monitoring in South Africa. J Clin Microbiol. 2024 Apr 10; 62(4):e0164923.
-
Higher CCR5 density on CD4 + T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission. AIDS. 2024 06 01; 38(7):945-954.
-
Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in Myanmar. J Clin Virol. 2024 04; 171:105653.
-
Characterization of HIV-1 Reservoirs in Children and Adolescents: A?Systematic Review and Meta-Analysis Toward Pediatric HIV Cure. J Pediatr. 2024 Apr; 267:113919.